Pharmacotherapy of recurrent respiratory papillomatosis

Bibliography

• CIUFFO G: Innesto positivo con filtrato di verruca vulgare. G. Ital. Mal. Venereal. (1907) 48:12–17.
   Google Scholar
• SHOPE R: Infectious papillomatosis of rabbits. Exp. Med. (1933) 58:607–624.
   PubMedGoogle Scholar
• LANCASTER WD, OLSON C: Animal papillomaviruses. Microbial. Rev. (1982) 46:191–207.
   PubMedGoogle Scholar
• DE VILLIERS EM: Heterogeneity of the human papillomavirus group. I. Vim/. (1989) 63:4898–4903.
   Google Scholar
• TERRY RM, LEWIS FA, GRIFFITHS S, WELLS M, BIRD CC: Demonstration of human papillomavirus types 6 and 11 in juvenile laryngeal papillomatosis by in-situ DNA hybridization. I Pathol. (1987) 153:245–248.
   Web of Science ®Google Scholar
• KASHIMA HK, KESSIS T, MOUNTS P, SHAH K: Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis. Otalaryngol. Head Neck Surg. (1991) 104:191–195.
   Google Scholar
• STEINBERG BM, TOPP WC, SCHNEIDER PS, ABRAMSON AL: Laryngeal papillomavirus infection during clinical remission. N Engl. Med. (1983) 308:1261–1264.
   PubMed Web of Science ®Google Scholar
• FERENCZY A, MITAO M, NAGAI N, SILVERSTEIN SJ, CRUM CP: Latent papillomavirus and recurring genital warts. N. Engl. J. Med. (1985) 313:784–788.
   PubMed Web of Science ®Google Scholar
• SHAH KV, HOWLEY PM: Papilloma-viruses. In Fields Virology SE Straus (Ed.) W.B. Lippincott-Raven Publishers, Philadelphia, USA (1996):2077–2109.
   Google Scholar
• STEINBERG BM, GALLAGHER T, STOLER M, ABRAMSON AL: Persistence and expression of human papillomavirus during interferon therapy. Arch. Otalaryngol. Head Neck Surg. (1988) 114:27-32. Documents viral persistence and its relation to recurrent disease.
   Google Scholar
• SYRJANEN K, HAKAMA M, SAARIKOSKI S et al.: Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex. Transm. Dis. (1990) 17:15–19.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER A, KIRCHHOFF T, MEINHARDT G, GISSMANN L: Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. °Enter Gynecal. (1992) 79:683–688.
   Google Scholar
• CENTERS FOR DISEASE CONTROL: Division of STD/HIV Prevention 1992 Annual Report. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Atlanta, GA, USA (1993).
   Google Scholar
• BONNEZ W: Papillomavirus. In Clinical Virology FG Hayden (Ed.) W.B. Churchill Livingstone, New York, USA (1997):569–611.
   Google Scholar
• FRAUMENI JFJ, LLOYD JW, SMITH EM, WAGONER JK: Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in women. J. Nat. Cancer Inst. (1969) 42:455–468.
   PubMedGoogle Scholar
• GRAHAM S, PRIORE R, GRAHAM M, BROWNE R, BURNETT W, WEST D: Genital cancer in wives of penile cancer patients. Cancer (1979) 44:1870–1874.
   PubMed Web of Science ®Google Scholar
• BRINTON LA: Epidemiology of cervical cancer - overview. In The Epidemiology of Cervical Cancer and Human Papilloma virus. KV Shah (Ed.) IARC Scientific Publications, Lyon, France (1992):3–23.
   Google Scholar
• BONNEZ W, REICHMAN RC: Papillomaviruses. In The Principles and Practice of Infectious Diseases. R Dolin (Ed.) Churchill Livingstone, New York, USA (1995):1387–1400.
   Google Scholar
• ZUR HAUSEN H: Genital papillomavirus infections. Frog. Med. Vim]. (1985) 32:15–21.
   PubMedGoogle Scholar
• STOLER MH, BROKER TR: M situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum. Pathol (1986) 17:1250–1258.
   PubMed Web of Science ®Google Scholar
• ANDERSON MC, BROWN CL, BUCKLEY CH et al.: Current views on cervical intraepithelial neoplasia. J. Clin. Athol (1991) 44:969–978.
   PubMed Web of Science ®Google Scholar
• LORINCZ AT, REID R, JENSON AB, GREENBERG MD, LANCASTER W, KURMAN RJ: Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol (1992) 79:328–337.
   PubMed Web of Science ®Google Scholar
• DURST M, DZARLIEVA-PETRUSEVSKA RT, BOUKAMP P, FUSENIG NE, GISSMANN L: Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus Type 16 DNA. Oncogene (1987) 1:251–256.
   PubMed Web of Science ®Google Scholar
• STOREY A, PIM D, MURRAY A, OSBORN K, BANKS L, CRAWFORD L: Comparison of the M vitro transforming activities of human papillomavirus types. EMBO J. (1988) 7:1815–1820.
   PubMed Web of Science ®Google Scholar
• WOODWORTH CD, DONIGER J, DIPAOLO JA: Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J. Vim/. (1989) 63:159–164.
   Google Scholar
• KAWASHIMA M, FAVRE M, OBALEK S, JABLONSKA S, ORTH G: Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses. J. Invest. Dermatol (1990) 95:537–542.
   PubMed Web of Science ®Google Scholar
• TSUNOKAWA Y, TAKEBE N, NOZAWA S et al.: Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. Int. J. Cancer (1986) 37:499–503.
   PubMed Web of Science ®Google Scholar
• SHIRASAWA H, TOMITA Y, SEKIYA S, TAKAMIZAWA H, SIMIZU B: Integration and transcription of human papillomavirus Type 16 and 18 sequences in cell lines derived from cervical carcinomas. J. Gen. Viral. (1987) 68:583–591.
   PubMed Web of Science ®Google Scholar
• STOLER MH, RHODES CR, WHITBECK A, WOLINSKY SM, CHOW LT, BROKER TR: Human papillomavirus Type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol (1992) 23:117–128.
   PubMed Web of Science ®Google Scholar
• LANCASTER WD, CASTELLANO C, SANTOS C, DELGADO G, KURMAN RJ, JENSON AB: Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. Am. J. °Enter Gynecol (1986) 154:115–119.
   PubMed Web of Science ®Google Scholar
• DURST M, GLITZ D, SCHNEIDER A, ZUR HAUSEN H: Human papillomavirus Type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology (1992) 189:132–140.
   PubMed Web of Science ®Google Scholar
• CAMPION MJ, MCCANCE DJ, CUZICK J, SINGER A: Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet (1986) 2:237–240.
   PubMed Web of Science ®Google Scholar
• KOUTSKY LA, HOLMES KK, CRITCHLOW CW et al: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl. J. Med. (1992) 327:1272–1278.
   PubMed Web of Science ®Google Scholar
• DALING JR, SHERMAN KJ: Relationship between human papillomavirus infection and tumors of anogenital sites other than the cervix. In The Epidemiology of Cervical Cancer and Human Papillomavirus KV Shah (Ed.) IARC Scientific Publications, Lyon, France (1992):223–241.
   Google Scholar
• DEMETER LM, REICHMAN RC: Association of human papillomaviruses (HPV) with other female genital tract tumors. In Human Papillomavims Infection. MA (Ed.) Sydney, Australia. (1994).
   Google Scholar
• CHANG F, WANG L, SYRJANEN S, SYRJANEN K: Human papillomavirus infections in the respiratory tract. Am. J Otolaryngol (1992) 13:210–225.
   PubMed Web of Science ®Google Scholar
• MORK J, LIE AK, GLATTRE E et al.: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl. J. Med. (2001) 344:1125–1131.
   PubMed Web of Science ®Google Scholar
• HAJEK E: Contribution to the etiology of laryngeal papilloma in children. J. Laryngol Otol (1956) 70:166–168.
   PubMedGoogle Scholar
• KASHIMA HK, SHAH F, LYLES A et al.: A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope (1992) 102:9–13.
   PubMed Web of Science ®Google Scholar
• DERKAY CS: Task force on recurrent respiratory papillomas. A preliminary report. Arch. Otolaryngol Head Neck Surg. (1995) 121:1386–1391.
   PubMed Web of Science ®Google Scholar
• BISHAI D, KASHIMA H, SHAH K: The cost of juvenile-onset recurrent respiratory papillomatosis. Arch. Otolalyngol Head Neck Surg. (2000) 126:935–939.
   PubMed Web of Science ®Google Scholar
• STRONG M, VAUGHAN C, HEALY GB: Recurrent respiratory papillomatosis. In Laryngo- TrachealProblems In The Pediatric Patient. M Tji (Ed.) Springfield, Illinois, USA (1979):88–98.
   Google Scholar
• JONES S, MYERS G: Benign neoplasms of the larynx. Otolaryngol Clin. N Am. (1985) 17:151–178.
   Web of Science ®Google Scholar
• MORGAN AH, ZITSCH RP: Recurrentrespiratory papillomatosis in children: a retrospective study of management and complications. Ear Nose Throat J. (1986) 65:19–28.
   PubMedGoogle Scholar
• KRAMER SS, WEHUNT WD, STOCKER JT, KASHIMA H: Pulmonary manifestations of juvenile laryngotracheal papillomatosis. Am. J. Roentgenol (1985) 144:687–694.
   PubMed Web of Science ®Google Scholar
• COLE RR, MYER CM, COTTON RT: Tracheotomy in children with recurrent respiratory papillomatosis. Head Neck (1989) 11:226–230.
   PubMed Web of Science ®Google Scholar
• COOK TA, BRUNSCH WIG JP, BUTELJS, COHN AM, GOEPFERT H, RAWLS WE: Laryngeal papilloma: etiologic and therapeutic considerations. Ann. Otol Rhino]. Laryngol (1973) 82:649–655.
   PubMed Web of Science ®Google Scholar
• QUICK CA, WATTS SL, KRZYZEK RA, FARAS AJ: Relationship between condy-lomata and laryngeal papillomata. Clinical and molecular virological evidence. Ann. Otol Rhino]. Laryngol (1980) 89:467–471.
   PubMed Web of Science ®Google Scholar
• ABRAMSON AL, STEINBERG BM, WINKLER B: Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope (1987) 97:678–685.
   PubMed Web of Science ®Google Scholar
• SHAH K, KASHIMA H, POLK BF, SHAH F, ABBEY H, ABRAMSON A: Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet. Cynecol (1986) 68:795–799.
   Web of Science ®Google Scholar
• FREDERICKS BD, BALKIN A, DANIEL HW, SCHONROCK J, WARD B, FRAZER IH: Transmission of human papillomaviruses from mother to child. Aust. N Z Obstet. Cynaecol (1993) 33:30–32.
   PubMed Web of Science ®Google Scholar
• SHAH KV, STERN WE SHAH FK, BISHAI D, KASHIMA HK: Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr. Infect. Dis. J. (1998) 17:372–376.
   PubMed Web of Science ®Google Scholar
• YOSHPE NS: Oral and laryngeal papilloma: a pediatric manifestation of sexually transmitted disease? Int. J. Pediatr. Otorhinolaryngol (1995) 31:77–83.
   PubMed Web of Science ®Google Scholar
• MOUNTS P, KASHIMA H: Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Laryngoscope (1984) 94:28–33.
   PubMed Web of Science ®Google Scholar
• HARTLEY C, HAMILTON J, BIRZGALIS AR, FARRINGTON WT: Recurrent respiratory papillomatosis - the Manchester experience, 1974-1992.1 Laryngol Otol (1994) 108:226–229.
   PubMed Web of Science ®Google Scholar
• RIMELL FL, SHOEMAKER DL, POU AM, JORDAN JA, POST JC, EHRLICH GD: Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope (1997) 107:915–918.
   PubMed Web of Science ®Google Scholar
• RABAH R, LANCASTER WD, THOMAS R, GREGOIRE L: Human papillomavirus-1 1-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr. Develop. Pathol (2001) 4:68–72.
   PubMed Web of Science ®Google Scholar
• BJORK H, TEIR H: Benign and malignant papilloma of the larynx in adults. Acta Otolaryngol (Stockholm) (1957) 47:95–104.
   PubMedGoogle Scholar
• HOLINGER PH, SCHILD JA, MAURIZI DG: Laryngeal papilloma: review of etiology and therapy. Laryngoscope (1968) 78:1462–1474.
   PubMed Web of Science ®Google Scholar
• SOLOMON D, SMITH RR, KASHIMA HK, LEVENTHAL BG: Malignant transformation in non-irradiated recurrent respiratory papillomatosis. Laryngoscope (1985) 95:900–904.
   PubMed Web of Science ®Google Scholar
• KASHIMA H, WU TC, MOUNTS P, HEFFNER D, CACHAY A, HYAMS V: Carcinoma ex-papilloma: histologic and virologic studies in whole-organ sections of the larynx. Laryngoscope (1988) 98:619–624.
   PubMed Web of Science ®Google Scholar
• BONNEZ W, ROSE RC, DA RIN C, BORKHUIS C, DE MESY JENSEN KL, REICHMAN RC: Propagation of human papillomavirus Type 11 in human xenografts using the severe combined immunodeficiency (SCID) mouse and comparison to the nude mouse model. Virology (1993) 197:455–458.
   PubMed Web of Science ®Google Scholar
• KREIDER JW, HOWETT MK, WOLFE SA et al.: Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature (1985) 317:639–641.
   PubMed Web of Science ®Google Scholar
• MEYERS C, FRATTINI MG, HUDSON JB, LAIMINS LA: Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science (1992) 257:971–973.
   PubMed Web of Science ®Google Scholar
• DOLLARD SC, WILSON JL, DEMETER LM et al: Production of human papillo-mavirus and modulation of the infectious program in epithelial raft cultures. OFF Genes Dave]. (1992) 6:1131–1142.
   PubMed Web of Science ®Google Scholar
• CHOW LT, BROKER TR: ha vitro experimental systems for HPV: epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences. Clin. Dermatol (1997) 15:217–227.
   PubMed Web of Science ®Google Scholar
• BAUMAN NM, SMITH RJ: Recurrent respiratory papillomatosis. Pediatr. Clin. N Am. (1996) 43:1385–1401.
   PubMed Web of Science ®Google Scholar
• MYER CM, WILIGING P, COTTON R: Use of a laryngeal microresector system. Laryngoscope (1999) 109:1165–1166.
   PubMed Web of Science ®Google Scholar
• •Description of surgical device increasingly used in management of RRP.
   Google Scholar
• MCMILLAN K, SHAPSHAY SM, MCGILLIGAN JA, WANG Z, REBEIZ EE: A 585-nanometer pulsed dye laser treatment of laryngeal papillomas: preliminary report. Laryngoscope (1998) 108:968–972.
   PubMed Web of Science ®Google Scholar
• VALDEZ TA, MCMILLAN K, SHAPSHAY SM: A new laser treatment for vocal cord papilloma-58 5-nm pulsed dye. Otolaryngol Head Neck Surg. (2001) 124:421–425.
   PubMed Web of Science ®Google Scholar
• BERGLER W, HONIG M, GOTTE K, PETROIANU G, HORMANN K: Treatment of recurrent respiratory papillomatosis with argon plasma coagulation. Laryngol Otol (1997) 111:381–384.
   PubMed Web of Science ®Google Scholar
• BORDEN EC, FALL LA: Interferons: bichemical, cell growth, inhibitory, and immunological effects. Frog. Hematol (1981) 350:1–64.
   Google Scholar
• KIMBERLIN DW, PROBER CG: Antiviral agents and interferons. In Principles and Practice of Pediatric Infectious Diseases. CG Prober (Ed.) W.B. Saunders Company, USA (2002). In Press.
   Google Scholar
• DORR RT: Interferon alpha in malignantand viral diseases: a review. Drugs (1993) 45:177–211.
   PubMed Web of Science ®Google Scholar
• GEN GC, RANSOHOFF RIVI: Interferon induced antiviral actions and their regul-ation. Adv. Virus Res. (1993) 42:57–102.
   PubMed Web of Science ®Google Scholar
• RENAULT PF, HOOFNAGLE JH: Side effects of alpha interferon. Sem. Liver Dis. (1989) 9:273–277.
   PubMed Web of Science ®Google Scholar
• MCDONALD EM, MANN AH, THOMAS HC: Interferons as mediators of psychiatric morbidity. Lancet (1987) 2:1175–1178.
   PubMed Web of Science ®Google Scholar
• GROUP CHC: Treatment of chronic viral hepatitis with alpha interferon: a consensus conference report. Canad. J. Infect. Dis. (1994) 5:107–112.
   PubMedGoogle Scholar
• HEALY GB, GELBER RD, TROWBRIDGE AL, GRUNDFAST KM, RUBEN RJ, PRICE KN: Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. N Engl. J. Med. (1988) 319:401–407.
   Google Scholar
• ••Randomised, controlled trial of IFNtherapy in RRP.
   Google Scholar
• LEVENTHAL BG, KASHIMA HK, MOUNTS P et al.: Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group. N Engl. I Med. (1991) 325:613–617.
   PubMed Web of Science ®Google Scholar
• •IFN therapy in RRP.
   Google Scholar
• HAGLUND S, LUNDQUIST PG, CANTELL K, STRANDER H: Interferon therapy in juvenile laryngeal papillomatosis. Arch. Otolaryngol (1981) 107:327–332.
   PubMed Web of Science ®Google Scholar
• SCHUURMAN AM, VAN DEN BROEK P: Results of treatment with alpha- interferon in adult-onset laryngeal papillomatosis. Clin. Otolaryngol Allied Sci. (1986) 11:447–453.
   PubMed Web of Science ®Google Scholar
• •IFN therapy in RRP.
   Google Scholar
• AVIDANO MA, SINGLETON GT: Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. (1995) 112:197–202.
   PubMed Web of Science ®Google Scholar
• BARLOW CF, PRIEBE CJ, MULLIKEN JB et al.: Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy.' Pediati: (1998) 132:527–530.
   PubMed Web of Science ®Google Scholar
• EICHER SA, TAYLOR-COOLEY LD, DONOVAN DT: Isotretinoin therapy for recurrent respiratory papillomatosis. Arch. Otolaryngol Head Neck Surg. (1994) 120:405–409.
   PubMedGoogle Scholar
• BELL R, HONG WK, ITRI LM, MCDONALD G, STRONG MS: The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot study. Am. Otolaryngol (1988) 9:161–164.
   PubMed Web of Science ®Google Scholar
• ENDRES DR, BAUMAN NM, BURKE D, SMITH RJ: Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study. Ann. Otol Rhino]. Laryngol (1994) 103:301–305.
   PubMed Web of Science ®Google Scholar
• KIROGLU M, CETIK F, SOYLU L et al:Acyclovir in the treatment of recurrent respiratory papillomatosis: a preliminary report. Am.j Otolaryngol (1994) 15:212–214.
   PubMed Web of Science ®Google Scholar
• ABRAMSON AL, SHIKOWITZ MJ, MULLOOLY VM, STEINBERG BM, AMELLA CA, ROTHSTEIN HR: Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch. Otolaryngol Head Neck Surg. (1992) 118:25–29.
   PubMedGoogle Scholar
• ABRAMSON AL, SHIKOWITZ MJ, MULLOOLY VM, STEINBERG BM, HYMAN RB: Variable light-dose effect on photodynamic therapy for laryngeal papillomas. Arch. Otolaryngol Head Neck Sing. (1994) 120:852–855.
   Web of Science ®Google Scholar
• BORKOWSKI G, SOMMER P, STARK T,SUDHOFF HL, UCKHAUPT H: Recurrent respiratory papillomatosis associated with gastroesophageal reflux disease in children. Ear: Arch. Oto-Rhino-Laryngol (1999) 256:370–372.
   PubMed Web of Science ®Google Scholar
• SHIKOWITZ MJ, ABRAMSON AL, FREEMAN K, STEINBERG BM, NOURI M: Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope (1998) 108:962–967.
   PubMed Web of Science ®Google Scholar
• •Photodynarnic therapy in RRP.
   Google Scholar
• OSTROW RS, FORSLUND KM, MCGLENNEN RC et al.: Ribavirin mitig-ates wart growth in rabbits at early stages of infection with cottontail rabbit papillo-mavirus. Antiviral Res. (1992) 17:99–113.
   PubMed Web of Science ®Google Scholar
• MCGLENNEN RC, ADAMS GL, LEWIS CM, FARAS AJ, OSTROW RS: Pilot trial of ribavirin for the treatment of laryngeal papillomatosis. Head Neck (1993) 15:504-512. Discussion. Head Neck (1993) 15:512–503.
   Google Scholar
• HARCOURT JP, WORLEY G, LEIGHTON SE: Cimetidine treatment for recurrent respiratory papillomatosis. Int. Pediatr. Otorhinolaryngol (1999) 51:109–113.
   PubMed Web of Science ®Google Scholar
• COLL DA, ROSEN CA, AUBORN K, POTSIC WP, BRADLOW HL: Treatment of recurrent respiratory papillomatosis with indole-3-carbinol. Am. Otolaryngol (1997) 18:283–285.
   PubMed Web of Science ®Google Scholar
• ROSEN CA, WOODSON GE, THOMPSON JW, HENGESTEG AP, BRADLOW HL: Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. (1998) 118:810–815.
   PubMed Web of Science ®Google Scholar
• •Indole-3-carbinol therapy in RRP.
   Google Scholar
• DERKAY CS: Recurrent respiratory pap-illomatosis. Laryngoscope (2001) 111:57–69.
   PubMed Web of Science ®Google Scholar
• SNOECK R, WELLENS W, DESLOOVERS C, VAN RANST M, DECLERCQ E, FEENSTRA L: Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3)hydroxy-2-(phosphonylmethoxypropy0 cytosine (cidofovir). Ninth International Conference on Antiviral Research. Eurabandi, Fukushima, Japan (19–24 May 1996).
   Google Scholar
• SNOECK R, WELLENS W, DESLOOVERE C et al.: Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxy-propyl)cytosinel. Med. Vim]. (1998) 54:219–225.
   Google Scholar
• •Cidofovir therapy in RRP.
   Google Scholar
• PRANSKY SM, MAGIT AE, KEARNS DB, KANG DR, DUNCAN NO: Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch. Otolaryngol Head Neck Sing. (1999) 125:1143–1148.
   Web of Science ®Google Scholar
• •Cidofovir therapy in RRP.
   Google Scholar
• PRANSKY SM, BREWSTER DF, MAGIT AE, KEARNS DB: Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch. Otolaryngol Head Neck Sing. (2000) 126:1239–1243.
   Web of Science ®Google Scholar
• BIELAMOWICZ S, VILLAGOMEZ V, STAGER SV, WILSON WR: Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope (2002) 112:696–699.
   PubMed Web of Science ®Google Scholar
• ABDULKARIM B, SABRI S, DEUTSCH E et al.: Antiviral agent cidofivir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene (2002) 21:2334–2346.
   PubMed Web of Science ®Google Scholar
• VAN VALCKENBORGH I, WELLENS W, DE BOECK K, SNOECK R, DE CLERCQ E, FEENSTRA L: Systemic cidofovir in papillomatosis. Clin. Infect. Dis. (2001) 32:E62–64.
   PubMed Web of Science ®Google Scholar
• ARMBRUSTER C, KREUZER A, VORBACH H, HUBER M, ARMBRUSTER C: Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b. Eur. Resp. (2001) 17:830–831.
   PubMed Web of Science ®Google Scholar
• AALTONEN LM, PELTOMAA J, RIHKANEN H: Prognostic value of clinical findings in histologically verified adult-onset laryngeal papillomas. Ear: Arch.Oto-Rhino-Laryngol (1997) 254:219–222.
   PubMed Web of Science ®Google Scholar
• KIMBERLIN DW, MALIS DJ: Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy. Antiviral Res. (2000) 45:83–93.
   PubMed Web of Science ®Google Scholar